Kingdom Holdings Ltd Stock
Price
Target price
€0.13
€0.13
2.400%
0.003
2.400%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Kingdom Holdings Ltd Stock
Kingdom Holdings Ltd gained 2.400% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kingdom Holdings Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Kingdom Holdings Ltd in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kingdom Holdings Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kingdom Holdings Ltd | 2.400% | 3.226% | 5.785% | -6.569% | -5.185% | -26.012% | 1.587% |
| Best Pacific Intl Hldgs Ltd. | - | 0.578% | 21.678% | 39.200% | -3.867% | 90.164% | 231.429% |
| Kap-beteiligungs-Ag | -0.560% | -3.243% | -9.596% | -12.255% | -6.771% | -54.337% | -27.236% |
| Dierig Holding AG | 0.000% | 0.000% | -1.724% | -9.043% | -2.286% | -39.362% | -32.143% |
News
Outlook Therapeutics Reports Q3 Revenue
Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company focused on ophthalmic treatments, released its third quarter fiscal 2025 results on August 14, 2025. The company posted its first-ever
Roadzen Posts 22% Q1 Revenue Gain
Roadzen (NASDAQ:RDZN), an insurance technology company specializing in artificial intelligence-powered solutions for underwriting, claims, and telematics, released its Q1 FY2026 earnings results on
Ampco-Pittsburgh Reports Record Profit
Ampco-Pittsburgh(NYSE:AP) reported second-quarter 2025 results on Aug. 12, posting a net loss of $7.3 million (GAAP) due to a $6.8 million United Kingdom plant exit charge. Management announced